Home » Topics » Regulatory

Regulatory
RSS

Feron approved in Japan for compensatory cirrhosis C

April 21, 2006

Pramipexole approved in Europe for restless legs syndrome

April 10, 2006

Myozyme approved for Pompe disease in Europe

April 4, 2006

Relenza approved for prophylactic use, GSK advances pandemic flu vaccines

April 3, 2006

Korean approval for Quinvaxem pentavalent vaccine

March 29, 2006

Aranesp approved for every-three-week dosing

March 28, 2006

Lyrica receives European approval for GAD

March 28, 2006

Swedish approval for Grazax for grass pollen allergy

March 16, 2006

Emsam approved for major depressive disorder

March 1, 2006

Eraxis approved to treat candidemia

Feb. 22, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.